TNBS-Induced Colitis

Reagents and chemicals

• TNBS is the haptenating reagent used to induce colitis after intrarectal administration, and ethanol is used as the carrier and mucosal-disrupting agent that enables TNBS access to colonic tissue proteins^[1][2][3].

• Vehicle control solution should contain ethanol without TNBS when distinguishing hapten-driven inflammation from ethanol-associated epithelial injury^[1][2].

Antibodies, probes, dyes, or kits

• Hematoxylin–eosin staining is used to evaluate mucosal ulceration, inflammatory infiltrate, epithelial damage, edema, and transmural injury^[1][2][7].

• ELISA, qPCR, Western blot, or immunohistochemistry can be used for inflammatory readouts such as TNF-α, IFN-γ, IL-6, IL-10, IL-12, and myeloperoxidase activity when these endpoints match the study question^[4][5][6][8].

Equipment and instruments

• Required equipment includes animal weighing scales, anesthesia equipment, flexible intrarectal delivery tubing or catheter, syringes or pipettes for TNBS instillation, dissection tools for colon collection, and histology equipment for fixation, embedding, sectioning, staining, and microscopy^[1][2][3].

Preparation Steps

• Use strain-, sex-, age-, and weight-matched rodents, acclimate animals before induction, and assign at minimum untreated or water-handled controls, ethanol-vehicle controls, and TNBS-treated groups because TNBS protocols vary substantially and ethanol itself contributes to mucosal injury^[1][2][3].

• Prepare TNBS freshly in ethanol at the concentration and dose selected for the species and disease-severity target; mouse protocol papers commonly use intrarectal TNBS in ethanol for acute disease, while chronic mouse models use repeated intrarectal administrations, often with escalating TNBS doses^[1][2][6].

Operation Steps

• Fast or prepare animals only when the selected published protocol requires it, anesthetize the animal, insert the catheter intrarectally to the protocol-defined depth, instill TNBS solution into the colon, and maintain the animal in a head-down or vertical position briefly after instillation to reduce leakage when specified by the protocol^[1][2][3].

• For acute TNBS colitis, monitor animals for several days after a single intrarectal TNBS administration; for chronic TNBS colitis, use repeated intrarectal TNBS administrations over multiple weeks, with systematic reviews reporting repeated dosing as the defining feature of chronic models^[1][2][6].

• Record body weight, stool condition, survival or morbidity, and clinical signs during the experiment, then collect colon tissue at the predefined endpoint for macroscopic damage scoring, colon weight or length assessment when included, histology, MPO activity, cytokine assays, RNA analysis, or protein analysis^[1][2][6][8].

Data Acquisition and Analysis

• Successful TNBS colitis is interpreted by concordant increases in clinical disease, macroscopic lesions, histologic inflammation, ulceration, and inflammatory biomarkers such as MPO activity and Th1-associated cytokines^{[1][2][4][5][8]}.

• Use ethanol-only animals as vehicle controls, score histology using predefined criteria, blind observers to treatment groups where possible, and analyze biological replicates at the animal level rather than treating multiple tissue sections from the same animal as independent replicates^[1][2][7].

Problem: Mortality or severe tissue necrosis is excessive.

• Possible Cause: TNBS dose, ethanol concentration, instilled volume, animal strain, or repeated dosing schedule is too aggressive.
• Literature-supported Solution: Reduce severity by using a published dose-escalation or validated protocol matched to strain and model duration, because reviews report substantial protocol variability and emphasize that TNBS induction conditions strongly affect severity^[2][3][6].

Problem: Colitis is weak or inconsistent.

• Possible Cause: TNBS did not adequately contact the distal colon, the solution leaked after instillation, or the dose was insufficient for the chosen strain.
• Literature-supported Solution: Use standardized intrarectal catheter placement, consistent instillation technique, and protocol-matched TNBS dosing because TNBS colitis depends on local intracolonic exposure and protocol standardization^[1][2][3].

Problem: Ethanol controls show marked injury.

• Possible Cause: Ethanol disrupts the mucosal barrier and can independently damage epithelium.
• Literature-supported Solution: Include ethanol-only controls and interpret TNBS effects against vehicle controls rather than untreated controls alone^[1][2][3].